Design Therapeutics, Inc. cotiza a 10.91 USD y tiene una capitalización bursátil de $683M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases…
| Periodo | 2026-11 | 2026-08 | 2026-04 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.32 | $-0.29 | $-0.27 |
| Estimado | $-0.35 | $-0.34 | $-0.33 | $-0.35 |
| Sorpresa | — | +5.9% | +12.1% | +22.9% |
| Métrica | DSGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -32.8% | -40.4% | +7.6% |
| ROA | -30.9% | -32.0% | +1.2% |
| Current Ratio | 17.14 | 2.84 | +14.30 |
| Debt / Equity | — | 0.28 | — |